Title:

Residency Training Program Director

Rank:

Assistant Professor

Department:

Radiation Medicine

Specialty:

Radiation Medicine

Residency:

Oregon Health & Science University, Portland, Oregon

Resident Year:

PGY-4, 2014 - 2015, Oregon Health & Science University, Portland, OR
PGY-2 (1st year Radiation Medicine) in 2012

Internship:

Internal Medicine Preliminary Year (PGY1), University of Oklahoma Health Sciences Center, Oklahoma City, OK, 2012

Undergraduate:

BS, Mechanical Engineering with Special Distinction, College of Engineering,University of Oklahoma, Norman, OK, 2006

Medical School:

MD, University of Oklahoma College of Medicine, Oklahoma City, OK 2011

Other Training:

Doris Duke Charitable Foundation Clinical Research Fellowship, University of California, San Francisco, Department of Radiation Oncology, 2008-2009
Certificate in the Training in Clinical Research Program (TICR), University of California, San Francisco Department of Epidemiology and Biostatistics

Award and Honors:

• Nima Nabavizadeh, MD is the 5th Resident to receive the RSNA Resident/Fellow Grant Award

• Doris Duke Charitable Foundation Clinical Research Fellowship 

• Member of Alpha Omega Alpha Medical Honor Society 

• Member of Gold Humanism Honor Society 

• American Society for Radiation Oncology (ASTRO) Annual Meeting Travel Grant 

• International Society for Magnetic Resonance in Medicine (ISMRM) Education Grant 

• Class of 1980 Scholarship, Coburn Scholarship, University of Oklahoma College of Medicine Scholarship

Hobbies:

Cycling, bicycle construction and restoration, hiking, skiing and discovering new music.

Language Fluency (other than English):

Persian (Farsi)

Publications:

Electromagnetic Navigational Bronchoscopy-guided Fiducial Markers for Lung Stereotactic Body Radiation Therapy: Analysis of Safety, Feasibility, and Interfraction Stability.
Nabavizadeh N, Zhang J, Elliott DA, Tanyi JA, Thomas CR Jr, Fuss M, Deffebach M.

Nabavizadeh N, Klifa C, Newitt D, Lu Y, Chen YY, Hsu H, Fisher C, Tokayasu T, Olshen AB, Spellman P, Gray JW, Hylton N, Park CC. Topographic enhancement mapping of the cancer-associated breast stroma using breast MRI. Integrative Biology. 2011 Apr;3(4):490-6

Beall DP, Datir A, D'Souza SL, D'Souza LS, Gunda D, Morelli J, Johnson MB, Nabavizadeh N. Percutaneous treatment of insufficiency fractures : principles, technique and review of literature. Skeletal Radiology. 2010 Feb;39(2):117-30. Review.

Abstracts:

Wu FY, Boehling N, Nabavizadeh N, Lamborn K, Barnes M, Chang S, McDermott M, Haas-Kogan D. Clinical Outcome and Prognostic Factors for Central Neurocytoma. ASTRO (American Society for Radiation Oncology) Annual Meeting 2011. Poster Presentation. http://download.journals.elsevierhealth.com/pdfs/journals/0360-3016/PIIS0360301611025788.pdf

Simeonova AO, Nabavizadeh N, Monaco D, Tanyi JA, Fuss M. Intensity-modulated Arc Radiotherapy (IMAT) Planning For Patients With Pancreatic Cancer: A Planning Study. ASTRO (American Society for Radiation Oncology) Annual Meeting 2011. Poster Presentation. http://download.journals.elsevierhealth.com/pdfs/journals/0360-3016/PIIS0360301611026411.pdf

Nabavizadeh N, Klifa C, Newitt D, Lu Y, Hattangadi J, Fisher C, Hylton N, Park C. MR Quantification of Abnormal Stromal Enhancement in the Periphery of Invasive Breast Tumors. ASCO (American Society for Clinical Oncology) Annual Meeting 2009. Poster Presentation. http://www.asco.org/ASCOv2/Meetings/Abstracts?&vmview=abst_detail_view&confID=65&abstractID=31034 

Kaprealian T, Nabavizadeh N, Sneed PK, Nakamura JL, Huang K, McDermott MW. Parameters Influencing Local Control of Meningiomas Treated with Radiosurgery. ASTRO (American Society for Radiation Oncology) Annual Meeting 2009. Poster Presentation. http://download.journals.elsevierhealth.com/pdfs/journals/0360-3016/PIIS0360301609016228.pdf

Nabavizadeh N, Klifa C, Chen Y, Newitt D, Lu Y, Hattangadi J, Fisher C, Hylton N, Park C. MRI and Histologic Quantification of Neoangiogenesis in Normal Appearing Breast Beyond the Tumor Margin: Implications for Local Treatment. ASTRO (American Society for Radiation Oncology) Annual Meeting 2009. Poster Presentation. http://download.journals.elsevierhealth.com/pdfs/journals/0360-3016/PIIS0360301609014837.pdf

Additional Links

• Safety and Efficacy of Accelerated Hypofractionation and Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma Patients With Varying Degrees of Hepatic Impairment
  
• Nima Nabavizadeh selected to represent ACR on the Collaborative Committee
  

• Dr. Nabavizadeh presents at the 56th Annual Chest Disease Conference
  
• Massive hemorrhage following definitive esophageal chemoradiation: teaching case of a fatal aortoesophageal fistula and lessons learned
  
• Drs. Nabavizadeh and Mitri attending Scientific &Career Development Retreat at ASCO Headquarters
  
• Close observation versus upfront treatment in hepatocellular carcinoma: are the exception points worth the risk?[NCBI]
  

• Dr. Nima Nabavizadeh was a visiting faculty scholar at University of Washington
  

• Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer [NCBI] [Oxford Academic]
  
• Drs. Nabavizadeh and Thomas on JAMA network viewpoint : Oncology Know No Borders
  
• Supply and Demand for Radiation Oncology in the United States: A Resident Perspective
  
• Association of Intervals Between Neoadjuvant Chemoradiation and Surgical Resection With Pathologic Complete Response and Survival in Patients With Esophageal Cancer
• 10th Annual Fall M1-M2 Radiation Medicine Open House
  
• Dr Nabsvizadeh, presents certificates of appreciation to visiting medical students
• Young investigator Award (CCF Orginization)
  
• Nima Nabavizadeh, MD the 5th OHSU Radiation Medicine to receive ASCO Young Investigator Award
• Dr. Nabavizadeh is lead author on a featured ASTRO membership survey
  
• Robbie Fain co-authors a short report in JAMA Oncology
  
• Dr. Nima Nabavizadeh is lead author for the 2013-15 Association of Resident in Radiation Oncology chief resident survey
  
• Clinical outcome and prognostic factors for central neurocytoma twenty year institutional experience
  [PubMed]
• Dr. Nabavizadeh Moderator of 2106 ARRO Seminar at ASTRO
  
• Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma
  
• Dr. Nima Nabavizadeh receives a $500 cash prize for 1st place in the annual research retreat
  
• Dr. Nabavizadeh is selected to attend the FLIMS17 Methods in Clinical Cancer Research workshop
  
• Dr. Nabavizadeh has been selected to serve a 2-year term on the ARRO Executive Committee
• Multiple original research papers selected for presentation at the 2014 Multidisciplinary Head & Neck Cancer Symposium, held Feb 20-22 at the JW Marriott Camelback Inn Resort & Spa, Scottsdale, AZ.
•  2013 American Radium Society meeting oral presentation on "INTERFRACTION STABILITY OF ELECTROMAGNETIC NAVIGATIONAL BRONCHOSCOPY-PLACED EMBOLIZATION COIL FIDUCIAL MARKERS FOR LUNG STEREOTACTIC BODY RADIATION THERAPY (SBRT)